Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') presented the subgroup analysis data from the Phase III COMPASSION-16 trial, evaluating cadonilimab, a first-in-class PD-1/CTLA-4 bispecific antibody, ...

Members of the Manchester community are coming together to remember an 11-month-old girl who was killed after being hit by an ...

The attorney who negotiated the $2.8 billion legal settlement for the NCAA said Friday that thousands of former athletes due ...